Keyphrases
Older Patients
100%
Hazard Ratio
100%
Acute Myeloid Leukemia
100%
Busulfan
100%
Myelodysplastic Syndrome
100%
Myeloablative Conditioning
100%
Non-relapse Mortality
75%
Progression-free Survival
50%
Myeloablative
50%
Overall Survival
25%
Complete Remission
25%
Comorbidity
25%
Tacrolimus
25%
Unrelated Donor
25%
Fludarabine
25%
Methotrexate
25%
Dosing Regimen
25%
Area under the Curve
25%
Graft-versus-host Disease Prophylaxis
25%
Poor Risk
25%
Low-dose Regimen
25%
Intravenous Busulfan
25%
Antithymocyte Globulin
25%
Comorbidity Index
25%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Myelodysplastic Syndrome
100%
Myeloablative Conditioning
100%
Busulfan
100%
Hazard Ratio
80%
Progression Free Survival
40%
Drug Dose Regimen
40%
Comorbidity
40%
Overall Survival
20%
Tacrolimus
20%
Low Drug Dose
20%
Fludarabine
20%
Graft Versus Host Reaction
20%
Methotrexate
20%
Prophylaxis
20%
Thymocyte Antibody
20%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
100%
Busulfan
100%
Myelodysplastic Syndrome
100%
Progression Free Survival
40%
Comorbidity
40%
Overall Survival
20%
Remission
20%
Tacrolimus
20%
Fludarabine
20%
Methotrexate
20%
Graft Versus Host Reaction
20%
Thymocyte Antibody
20%